Verapamil

Half-Life (t½)
PO: 5h · IV: 2.36h
Formula
C27H38N2O4
Molecular Weight
454.6 g/mol
PubChem CID
2520
Aliases
Calan, Isoptin

Pharmacological Mechanism

Non-dihydropyridine CCB — strongest cardiac (AV-nodal) effect of the class. Used for AF rate control, certain SVTs, hypertension, and migraine prophylaxis. Strong CYP3A4 + P-glycoprotein inhibitor → major DDI source. Constipation (~25%).

Half-Life & Elimination Curve (PO: 5h · IV: 2.36h)

100%50%25%12.5%0%0h0×t½5h1×t½10h2×t½15h3×t½20h4×t½25h5×t½0×t½ (0h): 100% remaining (~0.282 mg/L)1×t½ (5h): 50% remaining (~0.141 mg/L)2×t½ (10h): 25% remaining (~70.5 µg/L)3×t½ (15h): 12.5% remaining (~35.3 µg/L)4×t½ (20h): 6.3% remaining (~17.6 µg/L)5×t½ (25h): 3.1% remaining (~8.82 µg/L)
Plasma (PO)t½ Decay (5h)
  • 0×t½0h100% (0.282 mg/L)
  • 1×t½5h50% (0.141 mg/L)
  • 2×t½10h25% (70.5 µg/L)
  • 3×t½15h12.5% (35.3 µg/L)
  • 4×t½20h6.3% (17.6 µg/L)
  • 5×t½25h3.1% (8.82 µg/L)
Elimination t½5h (PO)
Rate Constant (ke)0.139 h⁻¹
Time to Peak (Tmax)3.55h
Est. Peak (Cmax)0.282 mg/L
Clearance (CL)18 L/h
97% Washout (5×t½)25h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Interactions

Chemical Structure & Identifiers

References